Prediction of extraintestinal manifestations in inflammatory bowel disease using clinical and genetic variables with machine learning

被引：0

作者：

Perez, T. ^{[1
,2
]}

Bustamante, M. L. ^{[3
]}

Perez, P. Reyes ^{[4
]}

Rivera, A. Medina ^{[4
]}

Avendano, C. ^{[5
]}

Azocar, L. ^{[6
]}

Estela, R. ^{[7
]}

Aguilar, N. ^{[6
]}

Melero, R. Segovia ^{[6
]}

Silva, V. ^{[7
]}

de la Vega, A. ^{[7
]}

Arriagada, E. ^{[7
]}

Javier, C. ^{[6
]}

Hernandez, E. ^{[6
]}

Pavez-Ovalle, C. ^{[6
]}

Hernandez-Rocha, C. ^{[6
]}

Miquel, J. F. ^{[6
]}

Alvarez-Lobos, M. ^{[6
]}

机构：

[1] Pontificia Univ Catolica Chile, Santiago, Chile

[2] Hosp San Borja Arriaran, Gastroenterol, Santiago, Chile

[3] Univ Chile, ICBM Programa Genet Med, Santiago, Chile

[4] Univ Nacl Autonoma Mexico, Lab Int Invest Genoma Humano, Mexico City, Mexico

[5] Pontificia Univ Catolica Chile, Dept Ciencias Comp, Santiago, Chile

[6] Pontificia Univ Catolica Chile, Gastroenterol, Santiago, Chile

[7] Hosp San Borja Arriaran, Gastroenterol, Santiago, Chile

来源：

JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷

关键词：

D O I：

10.1093/ecco-jcc/jjae190.1479

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P1305

引用

页码：i2352 / i2354

页数：3

共 50 条

[21] Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
Jurij Hanzel
Christopher Ma
Niels Vande Casteele
Reena Khanna
Vipul Jairath
Brian G. Feagan
Drugs, 2021, 81 : 333 - 347
[22] Extraintestinal Manifestations Associated with Inflammatory Bowel Disease
Brown, Shaun R.
Coviello, Lisa C.
SURGICAL CLINICS OF NORTH AMERICA, 2015, 95 (06) : 1245 - +
[23] Characterisation of Extraintestinal Manifestations in Inflammatory Bowel Disease, and Chronology of Extraintestinal relative to Intestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort
Vavricka, Stephan R.
Rogler, Gerhard
Gantenbein, Claudine
Spoerri, Muriel
Vavricka, Mareike Prinz
Navarini, Alexander A.
French, Lars
Safroneeva, Ekaterina
Fournier, Nicolas
Straumann, Alex
Froehlich, Florian
Fried, Michael
Michetti, Pierre
Schoepfer, Alain M.
SWISS MEDICAL WEEKLY, 2013, 143 : 14S - 14S
[24] Correction to: Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
Jurij Hanzel
Christopher Ma
Niels Vande Casteele
Reena Khanna
Vipul Jairath
Brian G. Feagan
Drugs, 2021, 81 : 1697 - 1697
[25] Diagnosis and Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease
Gupta, Abhinav
Choi, Sarah
SURGICAL CLINICS OF NORTH AMERICA, 2025, 105 (02) : 385 - 404
[26] EXTRAINTESTINAL AND SYSTEMIC MANIFESTATIONS OF INFLAMMATORY BOWEL-DISEASE
RANKIN, GB
MEDICAL CLINICS OF NORTH AMERICA, 1990, 74 (01) : 39 - 50
[27] Therapies in Inflammatory Bowel Disease Patients with Extraintestinal Manifestations
Juillerat, Pascal
Manz, Michael
Sauter, Bernhard
Zeitz, Jonas
Vavricka, Stephan R.
DIGESTION, 2020, 101 (SUPPL 1) : 83 - 97
[28] Extraintestinal Manifestations in Children Diagnosed with Inflammatory Bowel Disease
Kavcar, Zubeyr
Civan, Hasret Ayyildiz
Taskin, Didem Gulcu
Hatipoglu, Sadik Sami
MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2023, 57 (01): : 73 - 78
[29] EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
Dimopoulos, Christina
Hung, Kenneth
Proctor, Deborah
Ruggiero, Eilzabeth
Al-Bawardy, Badr
INFLAMMATORY BOWEL DISEASES, 2020, 26 : S19 - S20
[30] Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease
Livne-Margolin, M.
Ling, D.
Konyo, S. Attia
Haj, O.
Abitbol, C. M.
Ben-Horin, S.
Kopylov, U.
JOURNAL OF CROHNS & COLITIS, 2022, 16 : I429 - I430

← 1 2 3 4 5 →